ORCHESTRA BIOMED
Orchestra BioMed, Inc. is a biomedical innovation company focused on developing high impact, high value, evidence-based therapeutic solutions for medical procedures that address major medical conditions. Its main focus is on developing new therapies for cardiovascular diseases which are the leading cause of death worldwide, taking the lives of 17.7 million people each year, or 31% of all global deaths according to the World Health Organization. It was founded in 2017 and is headquartered in New Hope, Pennsylvania.
ORCHESTRA BIOMED
Industry:
Biotechnology Health Care Medical Medical Device
Founded:
2017-01-01
Status:
Active
Contact:
917-254-4900
Email Addresses:
[email protected]
Total Funding:
282.82 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Content Delivery Network Google Universal Analytics JsDelivr Cloudflare JS CDN JS BootstrapCDN JQuery CDN
Current Advisors List
Current Employees Featured
Founder
Investors List
Avenue Venture
Avenue Venture investment in Debt Financing - Orchestra BioMed
Terumo Corporation
Terumo Corporation investment in Series D - Orchestra BioMed
Perceptive Advisors
Perceptive Advisors investment in Series D - Orchestra BioMed
RTW Investments LLC
RTW Investments LLC investment in Series D - Orchestra BioMed
Medtronic
Medtronic investment in Series D - Orchestra BioMed
SternAegis
SternAegis investment in Series D - Orchestra BioMed
Terumo Corporation
Terumo Corporation investment in Corporate Round - Orchestra BioMed
SternAegis
SternAegis investment in Series B - Orchestra BioMed
Soleus Capital
Soleus Capital investment in Series B - Orchestra BioMed
RTW Investments LLC
RTW Investments LLC investment in Series B - Orchestra BioMed
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-05-17 | Vivasure Medical | Orchestra BioMed investment in Series D - Vivasure Medical | 23 M USD |
More informations about "Orchestra BioMed"
Orchestra BioMed - Crunchbase Investor Profile
Orchestra BioMed, Inc. is a biomedical innovation company focused on developing high impact, high value, evidence-based therapeutic solutions for medical procedures that address major medical conditions. Its main focus is …See details»
Our People - Orchestra BioMed
Prior to joining Orchestra BioMed, Mr. Little served as Chief Operating Officer at Neovasc, where he drove its successful acquisition by Shockwave Medical in April 2023. ... a San Francisco based nonprofit organization. From April 2014 …See details»
Therapeutic Areas in Artery Disease & Hypertension - Orchestra …
According to the World Health Organization, coronary artery disease is the primary cause in over 17.8 million deaths annually worldwide. The most common medical procedure used to treat …See details»
Orchestra BioMed - LinkedIn
Orchestra BioMed’s partnership-enabled business model focuses on forging strategic collaborations with leading medical device companies to drive successful global commercialization of products ...See details»
Orchestra BioMed - Funding, Financials, Valuation & Investors
Orchestra BioMed is a biomedical innovation company that provides high-impact solutions for large unmet needs in procedure-based medicine. Search Crunchbase. ... How much funding …See details»
Orchestra BioMed™ Announces Strategic Collaboration,
Jul 5, 2022 Orchestra BioMed™ Announces Strategic Collaboration, Closing of $110 Million Private Equity Financing and Plans to List on Nasdaq Through Merger with Health Sciences …See details»
Orchestra BioMed - Contacts, Employees, Board Members
Orchestra BioMed has 6 current employee profiles, including Chief Executive Officer and Founder David Hochman. David Hochman Chief Executive Officer and Founder. Darren Sherman …See details»
Winning Together in Medtech: Interview with …
David Hochman, the maestro behind Orchestra BioMed, shares his journey from conceiving the idea of the company to accelerating high-impact technologies through risk-reward-sharing partnerships with leading medical device …See details»
Orchestra BioMed to Participate in the Piper Sandler 36th
2 days ago Orchestra BioMed has a strategic collaboration with Medtronic, one of the largest medical device companies in the world, for development and commercialization of AVIM …See details»
Releases Details - Orchestra BioMed
Jan 27, 2023 Orchestra BioMed is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships with leading medical device …See details»
Our Approach - Orchestra BioMed
Our partnership-enabled business model focuses on forging strategic collaborations with and licensing patented technologies to leading medical device companies to drive successful …See details»
Orchestra BioMed™ Strengthens Management Team with …
New Hope, PA – Orchestra BioMed ™,Inc., (“Orchestra BioMed” or the “Company”), a biomedical innovation company providing high-impact solutions for large unmet needs in procedure-based …See details»
Orchestra BioMed™ Announces Strategic Collaboration, Closing of …
Jul 5, 2022 The closing of Orchestra BioMed’s $110 million Series D financing, including investments by Medtronic, funds managed by RTW Investments, LP (“RTW”), Perceptive …See details»
Orchestra BioMed Announces Initiation of BACKBEAT Pivotal
Jan 8, 2024 Orchestra BioMed and Medtronic, Inc., have an exclusive strategic collaboration for development and commercialization of AVIM therapy for hypertensive pacemaker population, …See details»
Orchestra BioMed Reports Third Quarter 2024 Financial Results …
Nov 12, 2024 Orchestra BioMed Reports Third Quarter 2024 Financial Results and Provides a Business Update Provided by GlobeNewswire Nov 12, 2024 9:12pm. NEW HOPE, Pa., Nov. …See details»
Orchestra BioMed Debuts as Nasdaq-Traded Company with Lead …
Jan 27, 2023 Orchestra BioMed Holdings, Inc. to commence trading on January 27 on Nasdaq Global Market under ticker symbol “OBIO” NEW HOPE, Pa., Jan. 27, 2023 (GLOBE …See details»
Biomedical Innovation News & Events | Orchestra BioMed
New Hope, PA, September 20, 2022 – Orchestra BioMed™, Inc., (“Orchestra BioMed” or the “Company”), a biomedical innovation company accelerating high-impact technologies to …See details»
Orchestra BioMed to Participate in the Piper Sandler 36th Annual ...
3 days ago NEW HOPE, Pa., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company …See details»
Orchestra BioMed Reports Third Quarter 2024 Financial
Nov 12, 2024 Orchestra BioMed has a strategic collaboration with Medtronic, one of the largest medical device companies in the world, for development and commercialization of AVIM …See details»
Orchestra BioMed to Participate in the Piper Sandler 36th Annual ...
3 days ago NEW HOPE, Pa., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the …See details»